Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - CYTOKINETICS INCFinancial_Report.xls
EX-31.1 - SECTION 302 CEO CERTIFICATION - CYTOKINETICS INCd338733dex311.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - CYTOKINETICS INCd338733dex312.htm
EX-10.43 - AMENDMENT NO. 1 TO CONSULTING AGREEMENT - CYTOKINETICS INCd338733dex1043.htm
10-Q - FORM 10-Q - CYTOKINETICS INCd338733d10q.htm

Exhibit 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18. U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Cytokinetics, Incorporated on Form 10-Q for the quarterly period ended March 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Cytokinetics, Incorporated.

Dated: May 4, 2012

 

/s/ Robert I. Blum

Robert I. Blum
President and Chief Executive Officer
(Principal Executive Officer)

/s/ Sharon A. Barbari

Sharon A. Barbari
Executive Vice President, Finance and
Chief Financial Officer
(Principal Financial Officer)